This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Sjogren's Syndrome
and you are
between 18 and 75
years old
This is a medium phase trial determining
the safety and dosage of the new treatment, as well as its efficacy.
Show me locations

The purpose

A single-center, self-control, open-label study of efficacy and safety of Iguratimod in patients with Sjögren's Syndrome

Provided treatments

  • Drug: Iguratimod

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03023592. The sponsor of the trial is Peking Union Medical College Hospital and it is looking for 30 volunteers for the current phase.
Official trial title:
A Preliminary Efficacy Study of Iguratimod in Patients With Sjögren's Syndrome